CPT vs JNJ · P/E 104, rev $5.3M vs P/E 17, rev $49.37B
Camden Property Trust (CPT) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Camden Property Trust (CPT) is a reit - residential company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported CPT revenue for 2026-06-30 was $5.3M. Net income was $61.2M. CPT currently screens at market cap $12.11B and trailing P/E 104.0.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
CPT currently screens at market cap $12.11B and trailing P/E 104.0. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the CPT and JNJ stock pages for the full models.
Not investment advice.